The sale is pre-scheduled under a 10b5-1 plan, so no opportunistic signal. Monitor future insider activity for any acceleration of sales outside the plan.
RCUS drugs
RCUS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 10 $28.92entry
- T+1 · 4mo ago −2.94%α −2.17% · $28.07
- T+5 · 4mo ago −7.88%α −7.32% · $26.64
- T+20 · 3mo ago −1.04%α −3.46% · $28.62
- T+60 · 6w ago −14.45%α −17.09% · $24.74
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Officer Juan Jaen filed Form 144 to sell 25,000 shares (approx. $749,000) under a 10b5-1 plan dated 02/27/2026. The trust associated with Jaen has been selling shares in June/July 2026. The sale is small relative to market cap and pre-planned, reducing informational content.
Key Facts
- Officer Juan Jaen intends to sell 25,000 shares of Class A Common Stock (~$749,000).
- Sale is under a Rule 10b5-1 trading plan adopted on 02/27/2026.
- The Juan Carlos Jaen and Anita Galeana 2000 Trust has been selling shares since June 22, 2026 (cumulative ~75,000 shares).
- Total shares outstanding: ~125.8 million; sale represents <0.02% of shares.
Financial Impact
Proposed sale of $749,000 in shares by officer under pre-existing 10b5-1 plan; negligible dilution.
Risk Factors
- Insider selling could increase if the 10b5-1 plan is expanded, but current plan is routine.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (RCUS), Batch item 1 | 0001958244-26-000445 |
| Document: 0001958244-26-000445-index.html | 0001958244-26-000445 |
| Document: 0001958244-26-000445.txt | 0001958244-26-000445 |
| 144 Filing (RCUS), Batch item 4 | 0001958244-26-000445 |
| Document: 0001958244-26-000445-index.html | 0001958244-26-000445 |
| Document: 0001958244-26-000445.txt | 0001958244-26-000445 |
Track record
13 reports on RCUS
2 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +4.24% at T+1 after the Oct 21, 2026 report. 2 of 4 went positive at some point.
Filters
- Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $16.95 Now $16.86 −0.53% settles Nov 23
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $18.95 to $16.86 Now $16.86 −11.03% ▼ −11.03% −9.34% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $17.69 to $17.77 Now $16.86 −4.69% ▲ +0.45% −2.84% vs SPY
- Oct 23, 202624d ago 8-K Bearish 5/10 Entry $17.76 to $18.19 Now $16.86 +5.07% ▼ −2.42% −3.68% vs SPY
- Oct 22, 202625d ago 424B5 Bearish 6/10 Entry $18.54 to $18.19 Now $16.86 +9.06% ▲ +1.89% +1.33% vs SPY
- Oct 21, 202626d ago 424B5 Bearish 5/10 Entry $19.36 to $18.61 Now $16.86 +12.91% ▲ +3.87% +4.58% vs SPY
- Oct 21, 202626d ago 8-K Neutral 4/10 Entry $19.36 to $18.61 Now $16.86 −12.91% ▼ −3.87% −4.58% vs SPY
- Oct 20, 202627d ago 8-K Neutral 4/10 Entry $23.75 to $18.14 Now $16.86 −29.01% ▼ −23.62% −23.70% vs SPY
- Jul 9, 202618w ago 144 Neutral 3/10 Viewing Entry $28.92 to $26.64 Now $16.86 −41.70% ▼ −7.88% −7.32% vs SPY
- Apr 21, 202629w ago DEFA14A Neutral 2/10 Entry $26.62 to $24.55 Now $16.86 −36.66% ▼ −7.79% −7.85% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers